Fact CheckerSign in

NCT05117775Completed

Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC.

Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence: an International Cohort Study of Electronic Health Records. HNC-TACTIC.

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

This will be an international, multicenter, retrospective, observational, and data-driven study using secondary data captured in EHRs. The extraction of the data captured in the EHRs will be performed with SAVANA's EHRead®, an innovative data-driven system based on Natural Language Processing (NLP) and machine learning. For all patients, the Index Date is defined as the timepoint within the study period when they fulfill ALL inclusion criteria and no exclusion criteria. Follow-up comprises the period between Index Date and the last EHR available within the study period. Additional variable-specific time windows may be considered to optimize data collection.

Status (registry)
Completed
Study type
Observational
Enrollment
10000 (actual)
First submitted
8 Oct 2021
Start date
6 Dec 2021
Primary completion date
28 Feb 2024
Lead sponsor
Savana Research
NCT number
NCT05117775

What you commit to

  • Study type: Observational
  • Participants enrolled: 10000
  • From 6 Dec 2021 to the primary completion date, 28 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients with follow-up of less than 6 months, except if deceased (any cause) in the 6 months after HNSCC diagnosis

Who the study is looking for

  • Patients ≥18 years old.
  • Patients diagnosed with HNSCC
  • For selected exploratory analyses, patients diagnosed with nasopharynx, paranasal sinus, and salivary gland tumors.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Savan Research S.L
Coordinator of this site? Confirm its status
MadridSpainUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.